How can I tell the difference between the flu and COVID-19?
— FOX News
How can I tell the difference between the flu and COVID-19?
— FOX News
President Trump on Thursday said his Democratic opponent Joe Biden “should leave the campaign” in the wake of the release of a Senate GOP report detailing Hunter Biden’s extensive overseas business dealings, claiming the former vice president “knew everything.”
— FOX News: Brooke Singman
Wiley Announces Quarterly Dividend,
HOBOKEN, N.J.–(BUSINESS WIRE)–John Wiley and Sons (NYSE:JWA)(NYSE:JWB), a global research and education company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.3425 per share on its Class A and Class B Common Stock, payable on October 21, 2020 to shareholders of record on October 6, 2020. The quarterly dividend is equivalent to an annual dividend of $1.37 per share. Earlier this year, the Board of Directors approved the Company’s 27th consecutive annual dividend increase.
To access Wiley’s first quarter fiscal year 2020 results, please see: https://newsroom.wiley.com/press-releases/press-release-details/2020/Wiley-Reports-First-Quarter-Fiscal-2021-Results/default.aspx
About Wiley
Wiley drives the world forward with research and education. Through publishing, platforms and services, we help researchers, professionals, students, universities, and corporations to achieve their goals in an ever-changing world. And for more than 200 years, we have delivered consistent performance to all our stakeholders. The Company’s website can be accessed at www.wiley.com.
Contacts
Investor Contact:
Brian Campbell
201.748.6874
Media Contact:
Katie Roberts
602.373.7233
karobroerts@wiley.com
Go to Source
Author: WebSupport@BusinessWire.com
Life sciences commercial organizations can now forecast sales, predict churn, analyze brand propensity and launch new products with BirdzAI
PISCATAWAY TOWNSHIP, N.J.–(BUSINESS WIRE)–#AI—P360, a leading developer of technology for life sciences companies, today announced major updates to its sales enablement platform BirdzAI. The BirdzAI platform now includes advanced Artificial Intelligence (AI) capabilities that enable real-time decision-making for sales organizations by providing deep insights derived from a wide variety of proprietary and tertiary datasets. Key features include sales forecasting, churn prediction, brand propensity analysis, next best action insights and more.
“By adding advanced artificial intelligence capabilities to our BirdzAI platform, we are helping life sciences companies eliminate the guesswork often associated with sales operations,” stated P360 CEO and Founder Anupam Nandwana. “For example, BirdzAI’s churn forecasting capabilities puts predictive forecasting for physician prescriptions directly in the hands of company representatives. Sales teams are able to see in real-time which brands a specific physician is prescribing, and which ones they might be stepping away from.”
BirdzAI, which is backed by P360’s robust Data360 commercial data hub, enables life sciences companies to manage their business processes and data from a single platform, eliminating manual work and operational delays. With BirdzAI remote teams are also able to share data with the enterprise without delay, no matter where they might be.
The BirdzAI platform also offers unique functionality for companies launching new drugs into the marketplace. Key features and tested processes include customer alignment, customer master data management, territory planning and sizing, call planning, incentive compensation strategy and payout, roster management and field and management reporting.
“Our data is as expansive as it is valuable, so we are always looking for new ways to leverage it more efficiently and effectively, said Greg Daly, Senior Analyst, Sales Operations at Osmotica Pharmaceuticals. “Partnering with P360 has allowed us to do just that. Their Machine Learning Models put our data to work for us, allowing us to spend more time applying the insights that our data contains, and less time finding them.”
BirdzAI is built on Microsoft Azure and is compatible with existing commercial infrastructure and integrates seamlessly with leading CRM and ERP systems.
Delivering a 360 view through the pharma, physician and patient ecosystem, P360 designs and deploys capabilities that ensure the highest efficiencies and returns on sales operations, data management, clinical trials, patient centricity, and IoT innovation. With expertise in supporting commercial operations for companies of all sizes, P360 has built an industry-leading platform that gives customers ownership of their data and the ability to leverage artificial intelligence and machine learning capabilities.
Earlier this year, P360 launched their industry first IoT Product Swittons for physician remote engagement. In addition, P360 CEO Anupam Nandwana was recently named to the PharmaVoice 100, which recognize the most inspirational, motivational and transformational individuals throughout the life-sciences industry. To learn more about P360, visit P360.com.
About P360
Based in Piscataway Township, New Jersey, P360 is a leading developer of technology for the life sciences industry. Product offerings include BirdzAI, PatientJourney360, Data360, Trials360 and Swittons. To learn more about P360, visit P360.com.
Contacts
Brian Fitzgerald
Brian.Fitzgerald@P360.com
808-754-0437
A former top official in the NSC has accused Trump Administration officials of political intervention in the pre-publication review process for John Bolton’s book.
— ABC News: Top Stories
Doctors treating Aleksei Navalny said he had been discharged after 32 days of treatment and could make a full recovery.
NYT: Melissa Eddy
Johnson & Johnson plans to enroll 60,000 participants in its Phase 3 trials. Dr. Anthony Fauci and other top U.S. health officials are scheduled to testify before a Senate panel today.
— NYT: Top Stories
A career official said political appointees “commandeered” the prepublication review process of John Bolton’s memoir.
— NYT: Michael S. Schmidt and Charlie Savage
Justice Ruth Bader Ginsburg was to lay in repose outside the Supreme Court Wednesday for an unprecedented public viewing.
— ABC News: Top Stories
Though his career was cut short by knee injuries, he was widely regarded as one of the greatest running backs in National Football League history.
— NYT: George Vecsey